• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?脑淀粉样蛋白生成是阿尔茨海默病型痴呆的原因还是结果?
J Alzheimers Dis. 2010;22(2):393-9. doi: 10.3233/JAD-2010-100846.
2
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.脑β-淀粉样蛋白测量和磁共振成像萎缩均能预测从轻度认知障碍到阿尔茨海默病的进展时间。
Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.
3
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.可溶性纤维前体tau蛋白和β-淀粉样蛋白在早期人类阿尔茨海默病中出现,并与疾病进展和认知衰退相关。
Acta Neuropathol. 2016 Dec;132(6):875-895. doi: 10.1007/s00401-016-1632-3. Epub 2016 Oct 21.
4
[Involvement of beta-amyloid in the etiology of Alzheimer's disease].β-淀粉样蛋白在阿尔茨海默病病因学中的作用
Brain Nerve. 2010 Jul;62(7):691-9.
5
Lifespan brain activity, β-amyloid, and Alzheimer's disease.寿命期大脑活动、β-淀粉样蛋白与阿尔茨海默病。
Trends Cogn Sci. 2011 Nov;15(11):520-6. doi: 10.1016/j.tics.2011.09.004. Epub 2011 Oct 7.
6
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.淀粉样β沉积、神经退行性变与散发性阿尔茨海默病认知衰退:一项前瞻性队列研究。
Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8.
7
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
8
The antimicrobial protection hypothesis of Alzheimer's disease.阿尔茨海默病的抗菌保护假说。
Alzheimers Dement. 2018 Dec;14(12):1602-1614. doi: 10.1016/j.jalz.2018.06.3040. Epub 2018 Oct 9.
9
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系:一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
10
Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.糖酵解系统功能障碍可预测阿尔茨海默病中的淀粉样蛋白沉积、神经退行性变和临床进展。
Alzheimers Dement. 2024 May;20(5):3251-3269. doi: 10.1002/alz.13789. Epub 2024 Mar 19.

引用本文的文献

1
The Clinical Role of Heart Rate Variability Assessment in Cognitively Impaired Patients and Its Applicability in Community Care Settings: A Systematic Review of the Literature.心率变异性评估在认知障碍患者中的临床作用及其在社区护理环境中的适用性:文献系统综述
Cureus. 2024 Jun 5;16(6):e61703. doi: 10.7759/cureus.61703. eCollection 2024 Jun.
2
Protective Effects of Flavonoids against Alzheimer's Disease: Pathological Hypothesis, Potential Targets, and Structure-Activity Relationship.黄酮类化合物对阿尔茨海默病的保护作用:病理假说、潜在靶点和构效关系。
Int J Mol Sci. 2022 Sep 2;23(17):10020. doi: 10.3390/ijms231710020.
3
Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.阿尔茨海默病药物 PBT2 与淀粉样β 1-42 肽的相互作用不同于其他 8-羟基喹啉螯合药物。
Inorg Chem. 2022 Sep 19;61(37):14626-14640. doi: 10.1021/acs.inorgchem.2c01694. Epub 2022 Sep 8.
4
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach.用于治疗阿尔茨海默病的有症状和疾病修饰治疗药物管线:迈向个体化多药理学以患者为中心的方法。
Int J Mol Sci. 2022 Aug 18;23(16):9305. doi: 10.3390/ijms23169305.
5
Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer's disease.过度磷酸化的 tau 通过诱导阿尔茨海默病中的坏死性凋亡和炎症来介导神经元死亡。
J Neuroinflammation. 2022 Aug 15;19(1):205. doi: 10.1186/s12974-022-02567-y.
6
Alzheimer's disease and epilepsy: The top 100 cited papers.阿尔茨海默病与癫痫:被引用次数排名前100的论文。
Front Aging Neurosci. 2022 Jul 22;14:926982. doi: 10.3389/fnagi.2022.926982. eCollection 2022.
7
Expression of the Excitatory Postsynaptic Scaffolding Protein, Shank3, in Human Brain: Effect of Age and Alzheimer's Disease.兴奋性突触支架蛋白Shank3在人脑中的表达:年龄和阿尔茨海默病的影响
Front Aging Neurosci. 2021 Aug 24;13:717263. doi: 10.3389/fnagi.2021.717263. eCollection 2021.
8
The Involvement of Lactosylceramide in Central Nervous System Inflammation Related to Neurodegenerative Disease.乳糖神经酰胺在与神经退行性疾病相关的中枢神经系统炎症中的作用
Front Aging Neurosci. 2021 Jul 19;13:691230. doi: 10.3389/fnagi.2021.691230. eCollection 2021.
9
Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction : Implication for a Potential Therapy of Alzheimer's Disease.龟甲鹿胶预防神经元线粒体功能障碍:对阿尔茨海默病潜在治疗的启示。
Front Pharmacol. 2021 May 13;12:690256. doi: 10.3389/fphar.2021.690256. eCollection 2021.
10
Alzheimer's Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation.阿尔茨海默病与癫痫:重叠治疗创新机遇的视角。
Neurochem Res. 2021 Aug;46(8):1895-1912. doi: 10.1007/s11064-021-03332-y. Epub 2021 Apr 30.

本文引用的文献

1
Higher soluble amyloid beta concentration in frontal cortex of young adults than in normal elderly or Alzheimer's disease.年轻成年人额叶皮质中可溶性淀粉样β蛋白浓度高于正常老年人或阿尔茨海默病患者。
Brain Pathol. 2010 Jul;20(4):787-93. doi: 10.1111/j.1750-3639.2010.00374.x. Epub 2010 Jan 12.
2
Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development.阿尔茨海默病转基因小鼠模型中β-分泌酶 1 的升高与突触/轴突病变和淀粉样蛋白形成有关:对神经突斑块发展的影响。
Eur J Neurosci. 2009 Dec;30(12):2271-83. doi: 10.1111/j.1460-9568.2009.07017.x. Epub 2009 Dec 10.
3
Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories.衰老的表观遗传氧化还原转移(EORS)理论统一了自由基和胰岛素信号转导理论。
Exp Gerontol. 2010 Mar;45(3):173-9. doi: 10.1016/j.exger.2009.11.007. Epub 2009 Nov 27.
4
Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses.β-淀粉样蛋白作为海马突触释放概率的内源性正向调节因子。
Nat Neurosci. 2009 Dec;12(12):1567-76. doi: 10.1038/nn.2433.
5
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.一项在轻度至中度阿尔茨海默病中进行的 bapineuzumab 多剂量递增的 2 期临床试验。
Neurology. 2009 Dec 15;73(24):2061-70. doi: 10.1212/WNL.0b013e3181c67808. Epub 2009 Nov 18.
6
The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential.健康与阿尔茨海默病中的β-分泌酶BACE:调控、细胞生物学、功能及治疗潜力
J Neurosci. 2009 Oct 14;29(41):12787-94. doi: 10.1523/JNEUROSCI.3657-09.2009.
7
Promising strategies for the prevention of dementia.预防痴呆症的有前景的策略。
Arch Neurol. 2009 Oct;66(10):1210-5. doi: 10.1001/archneurol.2009.201.
8
A physiological role for amyloid-beta protein:enhancement of learning and memory.淀粉样β蛋白的生理作用:增强学习和记忆。
J Alzheimers Dis. 2010;19(2):441-9. doi: 10.3233/JAD-2009-1230.
9
Physical activity, diet, and risk of Alzheimer disease.身体活动、饮食与阿尔茨海默病风险
JAMA. 2009 Aug 12;302(6):627-37. doi: 10.1001/jama.2009.1144.
10
Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations.突触活动可减少神经元内的β淀粉样蛋白,促进淀粉样前体蛋白(APP)向突触的转运,并防止与β淀粉样蛋白相关的突触改变。
J Neurosci. 2009 Aug 5;29(31):9704-13. doi: 10.1523/JNEUROSCI.2292-09.2009.

脑淀粉样蛋白生成是阿尔茨海默病型痴呆的原因还是结果?

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

机构信息

Center for Alzheimer's Disease and Related Disorders, Southern Illinois University School of Medicine, Carbondale, IL 62794, USA.

出版信息

J Alzheimers Dis. 2010;22(2):393-9. doi: 10.3233/JAD-2010-100846.

DOI:10.3233/JAD-2010-100846
PMID:20847431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3079347/
Abstract

The amyloid cascade hypothesis has guided much of the research into Alzheimer's disease (AD) over the last 25 years. We argue that the hypothesis of amyloid-β (Aβ) as the primary cause of dementia may not be fully correct. Rather, we propose that decline in brain metabolic activity, which is tightly linked to synaptic activity, actually underlies both the cognitive decline in AD and the deposition of Aβ. Aβ may further exacerbate metabolic decline and result in a downward spiral of cognitive function, leading to dementia. This novel interpretation can tie the disparate risk factors for dementia to a unifying hypothesis and present a roadmap for interventions to decrease the prevalence of dementia in the elderly population.

摘要

淀粉样蛋白级联假说指导了过去 25 年来对阿尔茨海默病(AD)的大部分研究。我们认为,淀粉样蛋白-β(Aβ)作为痴呆主要原因的假说可能并不完全正确。相反,我们提出,与突触活动密切相关的大脑代谢活性的下降实际上是 AD 认知能力下降和 Aβ沉积的基础。Aβ 可能进一步加剧代谢下降,导致认知功能的螺旋式下降,从而导致痴呆。这种新的解释可以将痴呆的不同风险因素与一个统一的假说联系起来,并为干预措施提供路线图,以降低老年人群中痴呆的患病率。